Navigation Links
Orasi Medical Completes Series B Financing - $3.5M
Date:5/20/2009

EDINA, Minn., May 20 /PRNewswire/ -- Orasi Medical, Inc. announced today that it has completed a $3.5 million Series B financing round.

The company will use this capital to expand the development and use of its diagnostic test into the pharmaceutical and clinical markets. Pharmaceutical companies will use this test to determine the efficacy of compounds intended to treat various neurological diseases. Orasi is currently in discussions with several pharmaceutical companies to finalize the structure of these clinical trials and the inclusion of the Orasi test. "In light of the difficult financial markets today we are very pleased with investor response to the Orasi offering. Pharmaceutical companies face a very difficult task in measuring the effect of neurological drugs; the Orasi products provide a novel approach to measuring treatment effect earlier and more accurately than current practice. This round of capital allows the company the opportunity to substantially advance this technology," stated Shawn Lyndon, Orasi's President and CEO. Orasi Medical is a technology spin out from the University of Minnesota co-founded by Shawn Lyndon and Mark Wagner.

About Orasi Medical, Inc.

Orasi Medical, Inc. is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and track the progression of neurological disorders using electrical brain activity. Orasi has developed a novel, quick, patient-friendly test of brain function that allows accurate assessment of disease progression and the effect of neurological treatments. Orasi collaborates with pharmaceutical companies to provide a robust and reproducible measure of drug mechanism, pharmacodynamics, and efficacy.

For more information, visit www.orasimedical.com


'/>"/>
SOURCE Orasi Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Council for American Medical Innovation Applauds the Confirmation of Margaret Hamburg, M.D., to Lead U.S. Food and Drug Administration
2. Indiana Podiatric Medical Association Endorses A-Claim Payment Solution
3. Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award
4. U.S. Health Care System Fails to Protect Patients From Deadly Medical Errors
5. California Medical Association Joins MedicAlert Foundation to Offer Medical Identification for Members and Patients
6. Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council
7. Thomson Reuters Medical Director Named to Healthcare Industry Leadership Roles
8. MDS Nordion Provides Update on AECLs Medical Isotope Supply Disruption
9. Next generation of health care workers train through medical simulation
10. Universal CRT Replacement Gives New Life to Medical Equipment with Analog Video
11. Eklin Medical Systems Appoints Juan Thorn as West Coast Ultrasound Sales Representative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: